文献速递免疫规划卫生政策与健康促进

日本COVID-19疫苗有效性和安全性评估系统的开发:VENUS研究

Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study.
PubMed 文献 · Vaccine · 2023-03-29

日本尚无同时主动监测COVID-19疫苗接种与未接种人群的疫苗评估系统。本研究开发了日本首个具备主动监测能力的COVID-19疫苗有效性与安全性评估系统(VENUS研究),链接四个市町村的四类个体级数据,使用五种匹配算法链接数据,链接率为85.4%至91.7%,该系统可监测疫苗接种、病例和PCR检测数。

要点

  • VENUS研究链接居民基本台账、疫苗接种记录、HER-SYS和医疗索赔四类数据。
  • 采用五种基于姓名、出生日期和性别的匹配算法,链接率为85.4%至91.7%。
  • 该系统可监测COVID-19疫苗接种、病例和PCR检测数,并支持主动监测和比较分析。

核心结论

  • 若在使用时审慎理解各数据源的特征,VENUS研究可提供可行的数据平台,促进日本基于人群的COVID-19疫苗有效性和安全性研究的主动监测和比较分析。

研究设计与样本

  • VENUS研究开发为多源数据库,在个体居民层面链接四类数据:居民基本台账(基础人口信息)、疫苗接种记录系统(疫苗接种相关信息)、COVID-19健康中心实时信息共享系统(HER-SYS;COVID-19发生信息)和医疗索赔数据(诊断、住院、诊断检测和治疗信息)。
  • 数据来自四个市町村,使用五种基于姓名、出生日期和性别的匹配算法在数据类型间链接个体居民,链接后数据匿名化。

主要发现

  • 该多源数据库能够在大流行期间监测COVID-19疫苗接种、COVID-19病例和PCR检测数。
  • 使用五种算法,HER-SYS中COVID-19发生信息与居民基本台账之间的数据链接率范围为85.4%至91.7%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are currently no COVID-19 vaccine assessment systems in Japan that allow for the active surveillance of both vaccinated and unvaccinated persons. Herein, we describe the development of Japan's first COVID-19 vaccine effectiveness and safety assessment system with active surveillance capabilities. METHODS: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study was developed as a multi-source database that links four data types at the individual resident level: Basic Resident Register (base population information), Vaccination Record System (vaccination-related information), Health Center Real-time Information-sharing System on COVID-19 (HER-SYS; information on COVID-19 occurrence), and health care claims data (information on diagnoses, hospitalizations, diagnostic tests, and treatments). These data were obtained from four municipalities. Individual residents were linked across the data types using five matching algorithms based on names, birth dates, and sex; the data were anonymized after linkage. To ascertain the viability of the VENUS Study's database for COVID-19 vaccine assessments, we examined the trends in COVID-19 vaccinations, COVID-19 cases, and polymerase chain reaction (PCR) test numbers. We also evaluated the linkage rates across the data types. RESULTS: Our multi-source database was able to monitor COVID-19 vaccinations, COVID-19 cases, and PCR test numbers throughout the pandemic. Using the five algorithms, the data linkage rates between the COVID-19 occurrence information in the HER-SYS and the Basic Resident Register ranged from 85·4% to 91·7%. CONCLUSION: If used judiciously with an understanding of each data source's characteristics, the VENUS Study can provide a viable data platform that facilitates active surveillance and comparative analyses for population-based research on COVID-19 vaccine effectiveness and safety in Japan.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fukuda H, Maeda M, Murata F, et al. Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study. Vaccine. 2023. PMID: 37037707. doi:10.1016/j.vaccine.2023.03.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。